Skip to search formSkip to main contentSkip to account menu
Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997).
TLDR
A potential therapeutic role for gatifloxacin that would widen the potency or spectrum of fluoroquinolones, particularly against Gram-positive species, when considering its favorable bioavailability is indicated.
View on PubMed
Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance…
View on PubMed
BAY 12-8039, a novel fluoroquinolone. Activity against important respiratory tract pathogens.
View on PubMed
In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus…
View on PubMed
Comparative In Vitro Activity of Gatifloxacin Against Stenotrophomonas maltophilia and Burkholderia Species Isolates Including Evaluation of Disk Diffusion and E Test Methods
TLDR
The activity of gatifloxacin is comparable to that of other newer quinolones against isolates of Stenotrophomonas maltophilia and Burkholderia spp.
View on Springer
In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp.
View on PubMed
Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium…
View on PubMed
Russian Klebsiella pneumoniae isolates that express extended-spectrum beta-lactamases.
View on PubMed
Antimicrobial Activity of Gatifloxacin Against Stenotrophomonas maltophilia and Burkholderia spp.
TLDR
Gatifloxacin is a new 8-methoxy fluoroquinolone which, like many recently evaluated quinolones, has a broadened spectrum of activity for Gram-positive organisms and anaerobes and is focused on against multiply resistant isolates of S. maltophilia, B. cepacia and B. pickettii.
View on Springer
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License